Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
BH4 Oxidation Links H2O2 to ERK1/2 in DRG Neurons
2026-08-26
The reference study identifies oxidation-derived H2O2, rather than BH4 itself, as the signal that increases ERK1/2 phosphorylation in rat dorsal root ganglion neurons. Its pharmacological data place B-Raf upstream of MEK1/2 and ERK1/2, revealing a potentially selective mechanism for studying BH4-associated nociceptor sensitization without broadly reducing BH4 levels.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-26
The reference study identifies CD44 as a functional metabolic dependency in IDH-mutant leukemia, linking R-2HG-driven signaling to pentose phosphate pathway activation, glycolysis suppression, and sustained NADPH production. Its isogenic CRISPR design supports a model in which combined mutant IDH and CD44 pathway inhibition could address incomplete responses to IDH-directed therapy.
-
Nifedipine (BAY-a-1040) Research Workflows
2026-08-25
Build controlled calcium-signaling, iron-transport, fungal, and liver-metabolism assays with Nifedipine (BAY-a-1040). This workflow guide separates established calcium channel applications from exploratory experiments inspired by PXR-driven liver regeneration and CYP induction.
-
Phosphosignal Preservation in Fatty Liver Research
2026-08-25
Phosphorylation can define whether a liver sample reveals active signaling or an ex vivo artifact. This thought-leadership article connects the SREBP-1c–CSE/H2S–ULK1 axis in hepatic steatosis with disciplined lysate handling and shows how Phosphatase Inhibitor Cocktail 3 supports translational phosphoprotein analysis.
-
AG-120 (Ivosidenib) AML Research Workflow
2026-08-24
Build a mechanism-led AML workflow around AG-120 (Ivosidenib), connecting mutant IDH1 inhibition to 2-hydroxyglutarate reduction, differentiation, and metabolic dependency assays. The design separates target engagement from nonspecific cytotoxicity and extends the reference study’s CD44 findings into practical combination-testing strategies.
-
Ibrexafungerp Activity Against Resistant Candida auris
2026-08-24
Wiederhold and colleagues showed that ibrexafungerp retained in vitro activity against fluconazole-resistant Candida auris and improved outcomes in a neutropenic mouse model even when therapy began after infection was established. The study is important because it links an orally available glucan-synthase inhibitor to a delayed-treatment design that more closely reflects a clinically challenging invasive candidiasis scenario.
-
Phosbind Acrylamide for Mechanistic Phospho Assays
2026-08-23
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis through phosphate-dependent mobility shifts in SDS-PAGE. This article connects the assay principle to the OsSTRK1–OsGSK2 brassinosteroid study and explains how to distinguish screening evidence from site-specific mechanistic proof.
-
PtrbZIP12 Links Drought Defense to PtrDHN and PtrPOD
2026-08-22
This study defines PtrbZIP12 as a positive regulator of drought tolerance in Populus trichocarpa and identifies PtrDHN and PtrPOD as direct transcriptional targets. By connecting promoter binding, ROS control, proline accumulation, and phosphorylation-dependent regulation, it provides a mechanistic framework for studying drought-responsive transcription factors in trees.
-
Nitrocefin Workflow for β-Lactamase Assays
2026-08-22
Build a practical Nitrocefin workflow for rapid β-lactamase activity measurement, inhibitor screening, and resistance-mechanism studies. The guide connects colorimetric bench assays with the 2024 MDockPeP2_VS peptide-screening study while emphasizing controls, optimization, and interpretation limits.
-
Isochlorogenic Acid A: From Molecule to Wound Assay
2026-08-21
Explore Isochlorogenic acid A (3,5-Dicaffeoylquinic acid) through its molecular properties, formulation constraints, and emerging wound-repair applications. This evidence-led guide translates a recent hydrogel study into practical decisions for natural product, anti-infection, immunology, and inflammation research.
-
LARP1–Ribosome Binding in TOP mRNA Control
2026-08-20
Saba and colleagues define how LARP1 associates with non-translating ribosomal subunits and TOP mRNAs in repressed complexes. Their cryo-EM and biochemical evidence shows that ribosome binding is structurally distinctive but is not required for the canonical repression or stabilization of TOP transcripts, refining prevailing models of translational control.
-
Perphenazine Workflows for Neuropharmacology
2026-08-20
Perphenazine supports complementary neuropharmacology and host-directed antibacterial workflows, from dopamine D2 receptor studies to mitochondrial and macrophage assays. This guide translates its receptor profile, solubility, and published cell and animal findings into practical experimental designs and troubleshooting checkpoints.
-
AG-120 (Ivosidenib) Workflow for IDH1 AML
2026-08-19
Build a mechanism-led AML workflow around AG-120 (Ivosidenib), connecting mutant IDH1 inhibition with 2-hydroxyglutarate reduction, differentiation, and metabolic dependency assays. The practical framework combines isogenic controls, metabolite measurements, and CD44-axis analysis to distinguish target engagement from nonspecific cytotoxicity.
-
Protease and Phosphatase Inhibitor Cocktail Workflow
2026-08-19
Protect phosphorylation-dependent signaling and protein integrity with an EDTA-free, 100X formulation designed for rapid lysate stabilization. This workflow translates PTGER4 organoid research into practical choices for western blotting, immunoprecipitation, phosphoproteomics, and other protein assays.
-
β-Elemene Workflow for AMPK and Apoptosis
2026-08-18
β-Elemene connects adipogenesis, insulin-resistance, apoptosis, and neuroprotection assays through a practical, dose-controlled workflow. This guide translates recent 3T3-L1 findings into experimental steps while showing how Levo-β-elemene can support complementary cancer, inflammation, analytical, and neural research applications.